...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: The crick didn’t rise, here’s the presentation, finally!

Payzone

Just reading between the lines in the first paragraph of your post. If the TNBC trial was paused/suspended/stopped according to DM, that would have been Pfizer's decision since they are paying for the trial. 
"we decided to pause - we would rather pursue low-hangin fruit in non competitive markets" infers that Pfizer and Zenith collectively made the decision. 

Share
New Message
Please login to post a reply